DEPLOYMENT · US
PARAMOUNT Trial: First Randomized Study Validates AI-Enabled Plaque-Based Care Protocol
PARAMOUNT, a randomized controlled trial, met its primary endpoint for AI-guided plaque detection and interventional care at AHA 2026. First large RCT validating AI decision support in cardiology procedural workflow.
WHY IT MATTERS · EDITORIAL ANALYSIS
RCT validation of AI in clinical workflows sets precedent for BFSI-adjacent insurance and healthcare finance; insurers can now cite peer-reviewed evidence for AI-driven underwriting and claims decisions.
Source: News-Press NOW · 2026-11-07